Massachusetts General Hospital Cancer Center
    Massachusetts General Hospital
Home About Us How To Help Contact Us Search

Center for Cancer Risk Assessment

 

How To Locate Us

Directions

 

 

Welcome to Cancer Resource Room - Massachusetts General Hospital Cancer Center, Boston, MA

Learn About Cancer



Breast & Ovarian Cancer

Living with Cancer

 


Cancer Research Developments

What's New



Patient Education

Breast Cancer Genetics



< Previous Page

 

 

 

 

Breast and Ovarian Cancer Genetics Program
A Single Place...A World of Care

To Make An Appointment: 617-724-1971
Director: Paula D. Ryan, MD, PhD

Breast & Ovarian Genetics Services Genetics Specialists
Breast & Ovarian Genetics Research Breast & Ovarian Genetics Information

Services
Our program accepts patients with personal and/or family histories of breast and/or ovarian cancer. It is estimated that only approximately 5% of people with breast cancer and ~10% with ovarian cancer carry a hereditary predisposition to the disease. Genetic counseling is available by appointment in order to learn more about hereditary causes of breast and ovarian cancers as well as genetic testing options. In addition, patients have the option of participating in research studies.

Genetic Counseling, Center for Cancer Risk Analysis, Massachusetts General Hospital Cancer Center, Boston, MAIndividuals with following histories should consider cancer genetic counseling:

  • Personal history of ovarian cancer at any age
  • Personal history of early onset (below age 45) breast cancer
  • Personal history of breast cancer and at least one close family member with breast or ovarian cancer
  • Personal history of two (or more) breast cancers
  • Personal history of both breast and ovarian cancer
  • Family history of two or more close family members with breast or ovarian cancer
  • Family history of early-onset (below age 45) breast cancer
  • Family history of ovarian cancer at any age
  • Download program brochure (pdf)

Breast & Ovarian Cancer Genetics Research
Our program oversees clinical and laboratory research regarding the hereditary causes of breast and ovarian cancer. We are members of joint studies with other institutions as well as pursuing specific research at Massachusetts General Hospital/Partners Cancer Care. Studies include those focused on discovering new genes and the effects of known hereditary cancer genes. Patients have the option to participate in the following studies.


Frequency of 1100delC CHK2 mutation in hereditary families.
The purpose of this study is to determine the frequency of the 1100delC CHEK2 mutation in individuals with a personal and family history of specific cancers. Participation includes genetic counseling for 1100delC CHEK2 genetic testing, informed consent and blood draw. Participants receive 1100delC CHEK2 test results, typically via the genetic counselor.

Contact: Center for Cancer Risk Assessment 617-724-1971

REACH (Risk Evaluation And Cancer History)
The purpose of this study is to collect blood samples, medical records from cancer diagnoses and family history information in order to build a collection of information for future research questions. Participants in this study do not receive individual genetic research results but will be informed of any useful information learned from the overall research. Participation requires one (10 minute) conversation in person or over the phone with the genetic counselor for consenting and taking family history, filling out a consent form at home or person and one blood draw (3 tubes) at the hospital or any other facility.

Contact: Center for Cancer Risk Assessment 617-724-1971

Ovarian Cancer Prevention and Early Detection Study.
This is a GOG/CGN study to compare risk-reducing salpingo-oopherectomy vs. CA-125 screening of women at high genetic risk for ovarian cancer. Participants must undergo genetic counseling to ensure eligibility.

Contact: Center for Cancer Risk Assessment 617-724-1971

Genetic Basis of Multi-Cancer Families
The purpose of this study is to collect blood samples, medical records from cancer diagnoses and family history information in order to build a collection of information for future research questions regarding Li-Fraumeni Syndrome (LFS) families. Participants in this study do not receive individual genetic research results but will be informed of any useful information learned from the overall research. Participation requires one (10 minute) conversation in person or over the phone with the genetic counselor for consenting and taking family history, filling out a consent form at home or person and one blood draw (3 tubes) at the hospital or any other facility.

Contact: Center for Cancer Risk Assessment 617-724-1971

Genetics Specialists

Director
Paula D. Ryan, MD, PhD

Psychiatric Consultants
William F. Pirl, MD

Genetic Counselors
Lauren Carpiniello, MS
Devanshi Patel, MS
Kristen Mahoney Shannon, MS, CGC
Gayun Chan Smutko, MS

Breast & Ovarian Cancer Genetics Information
Download detailed information about hereditary causes of breast and ovarian cancers:

Additional sources of information:

 

 

Harvard Medical School - Teaching Affiliate  
< Back to Adult Cancer Care Previous Page | To Top